Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3358 results

Sort By:

Clinical Investigation Measuring the Long Term Clinical Performance and Safety of Biodentine™ XP in Patients Treated for Coronal Restorative or Endodontic Dental Indications.

Study ID: NCT06955429
Start Date: 2025-09-01
End Date: 2036-07-15
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

275

Intervention / Treatment

Dental restorative or endodontic treatment requiring Biodentine XP use

Sponsor

Septodont

Source: clinicaltrials.gov

Share:
Add to list

Neuronavigation-guided FUS-induced BBB Opening in Alzheimer's Disease Patients and Its Effects on Brain Amyloid and Tau

Study ID: NCT06600880
Start Date: 2025-06-30
End Date: 2026-12
Study Type

Interventional

Study Phase

Phase1

No. of Participants

6

Intervention / Treatment

Neuronavigation-guided single-element focused ultrasound transducer

Lumason

Magnetic Resonance Imaging (MRI) with or without gadolinium contrast agents

Positron Emission Tomography (PET)

Amyvid

MK-6240

Two

Blood draw

Ur5e

Urine test

Sponsor

Columbia University

Source: clinicaltrials.gov

Share:
Add to list

Investigating Metabolic and Psychological Adaptations in a Clinical Trial

Study ID: NCT06800794
Start Date: 2025-05-15
End Date: 2026-02-15
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

12

Intervention / Treatment

Behavioral Skill Training

Meal Provisioning

Sponsor

State University of New York at Buffalo

Source: clinicaltrials.gov

Share:
Add to list

Enhancing Oral Cancer Awareness Among Minorities

Study ID: NCT06682494
Start Date: 2025-07-15
End Date: 2026-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

Traditional Education

AI-powered Chatbox

Sponsor

Virginia Commonwealth University

Source: clinicaltrials.gov

Share:
Add to list

ViCToRy: Vorasidenib in Combination With Tumor Specific Peptide Vaccine for Recurrent IDH1 Mutant Lower Grade Gliomas

Study ID: NCT05609994
Start Date: 2025-06
End Date: 2029-08
Study Type

Interventional

Study Phase

Phase1

No. of Participants

48

Intervention / Treatment

PEPIDH1M vaccine + vorasidenib

Sponsor

Katy Peters, MD, PhD

Source: clinicaltrials.gov

Share:
Add to list

Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma

Study ID: NCT06860594
Start Date: 2025-06-04
End Date: 2027-06-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

30

Intervention / Treatment

Biospecimen Collection

Computed Tomography

Intensity-Modulated Radiation Therapy

Magnetic Resonance Imaging

Triapine

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

GentleFit Non-Invasive Ventilation (NIV) Interface Trial

Study ID: NCT06833294
Start Date: 2025-07-01
End Date: 2026-06-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

48

Intervention / Treatment

GentleFit Mask, Gentlefit Prong, Standard of Care Interface

Sponsor

Children's Hospital of Philadelphia

Source: clinicaltrials.gov

Share:
Add to list

Comparing High and Low Dose Iron Treatments for People on Peritoneal Dialysis: The PALaDIN Study

Study ID: NCT06884280
Start Date: 2025-10
End Date: 2027-10
Study Type

Interventional

Study Phase

Phase3

No. of Participants

30

Intervention / Treatment

Monofer (iron isomaltoside 1000)

Ferrous Sulfate

Sponsor

Hull University Teaching Hospitals NHS Trust

Source: clinicaltrials.gov

Share:
Add to list

Promoting Inclusive Education Through Executive Functions

Study ID: NCT05472194
Start Date: 2025-09
End Date: 2027-12-09
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

470

Intervention / Treatment

InSchool Training Program

Regular school activities

Sponsor

University of Minho

Source: clinicaltrials.gov

Share:
Add to list

Evaluation of the EF192B Protection Versus No Treatment

Study ID: NCT06752460
Start Date: 2025-08-31
End Date: 2025-10-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

72

Intervention / Treatment

In 192 b

Sponsor

Eurofarma Laboratories S.A.

Source: clinicaltrials.gov

Share:
Add to list